This study used Monte Carlo simulations to examine the ability of the two-stage least squares (2SLS) estimator and two-stage residual inclusion (2SRI) estimators with varying forms of residuals to estimate the local average and population average treatment effect parameters in models with binary outcome, endogenous binary treatment, and single binary instrument. The rarity of the outcome and the treatment was varied across simulation scenarios. Results showed that 2SLS generated consistent estimates of the local average treatment effects (LATE) and biased estimates of the average treatment effects (ATE) across all scenarios. 2SRI approaches, in general, produced biased estimates of both LATE and ATE under all scenarios. 2SRI using generalized residuals minimized the bias in ATE estimates. Use of 2SLS and 2SRI is illustrated in an empirical application estimating the effects of long-term care insurance on a variety of binary health care utilization outcomes among the near-elderly using the Health and Retirement Study.
| INTRODUCTION
Instrumental variables (IV) methods are used to obtain causal estimates of the effects of endogenous variables on outcomes using observational data. These methods mediate potential bias from unmeasured confounders affecting observed treatment through identifying and specifying an instrumental variable, which may represent a "natural experiment" affecting treatment through satisfying two principle assumptions: The instrument is sufficiently correlated with the endogenous variable (strength), and the instrument is uncorrelated with the error term in the outcome equation (validity) . IV methods are usually implemented using a two-stage approach where the first stage estimates an expectation of the endogenous variable conditional on measured confounders and one or more IV. The second stage model then predicts outcomes as a function of the estimated treatment values from the first stage, measured confounders, and potentially other control variables.
In what has been popularly dubbed as the two-stage least squares (2SLS) approach, the first and second stage models are parametrized using ordinary least squares regression, where the model fit is chosen through minimizing the sum of squared residuals from linear models. The 2SLS approach is a special case of the more general two-stage predictor substitution (2SPS) method, which follows the procedure described above but may apply alternative methods for estimating first-and second-stage models. Alternatively, one can obtain the residuals from the first stage regression and then run the second-stage regression with the original endogenous variable, observed confounders and the residuals from the first stage as an added covariate. This approach, known as the two-stage residual inclusion (2SRI) approach, is analogous to the 2SLS approach when both first-and second-stage models are linear.
These estimation methods were originally derived in a linear setting with continuous endogenous treatments and continuous outcome measures. The target parameter for these estimations is the average causal effect, which is the average of the partial derivative of a continuous outcome with respect to a continuous endogenous variable. However, these estimators but are often applied to what may be considered an inherently nonlinear setting, such as with binary treatment or outcome measures. When treatment (exposure) or outcome is binary and therefore has a conditional expectation that follows a probability scale, a nonlinear model featuring a convenient cumulative density function is often used to model the conditional mean of the treatment indicator in the first stage or outcome in the second stage. Popular approaches include using probit or logit regression models.
In these settings, it is well established that the 2SPS approach produces biased estimates of the population average treatment effect (ATE; Blundell & Powell 2003; Terza, Basu, & Rathouz, 2008) . Under full parametric assumptions of joint-normality, bivariate probit models can be used to model the two stages simultaneously (Bhattacharya, Goldman, & McCaffrey, 2006) and estimate the ATE.
Alternatively, it has been suggested that nonlinear 2SRI is the appropriate approach for estimation when first-or second-stage models have a dependent variable that is binary or otherwise suited for nonlinear regression; especially when full parametric assumptions, where statistical joint distribution of error terms of the exposure and outcomes are specified, are not wanted (Blundell & Powell, 2003 , 2004 Terza et al., 2008) . Nonlinear 2SRI methods identify the ATE through relying on the concepts that support control function methods (Blundell & Powell, 2003 , 2004 , which were developed in the context of continuous endogenous variables. However, the applicability of nonlinear 2SRI to models with binary endogenous treatments remains contentious.
Finally, with a nonlinear data generating process for outcomes, treatment effects are heterogeneous by construction. This raises complexity and confusion in that the specific treatment effect parameter identified by the 2SLS or 2SRI approaches may differ and generally depends on whether treatment effects are heterogeneous across the population and vary across levels of observed or unobserved confounders (aka essential heterogeneity). In such a situation, it is well established that traditional IV approaches such as 2SLS identify an average treatment effect across only the subgroup of "marginal" individuals whose treatment choices were affected by changes in the specified instrumental variable(s) (Basu, Heckman, Navarro-Lozano, & Urzua, 2007; Heckman, 1997; Heckman, Urzua, & Vytlacil, 2006) . When the instrumental variable is binary (which is the focus of this paper), this effect is known as the local average treatment effect (LATE; Imbens & Angrist, 1994) . It is an average of the treatment effects for each individual at the margin, or the marginal treatment effects, whose treatment choice would be affected by the change in the level of the instrument (Basu et al., 2007; Heckman, 1997; Heckman et al., 2006; Kowalski, 2016) . Both 2SLS and the analogous strictly linear application of 2SRI will generate consistent estimates of LATE as long as the linear mean model specifications in both stages are correct. 1 Terza, Bradford, and Dismuke (2007) and Terza et al. (2008) claimed that nonlinear 2SRI, but not 2SLS or 2SPS, produced consistent estimates of ATE in models with inherently nonlinear dependent variables. However, it is not clear which treatment effect parameter is being estimated under a 2SRI approach for a binary treatment. Particularly in applications with binary IVs, the 2SRI approach relies on functional form assumptions for identification (as explained below) that are difficult to test in most applied setting and many analysts, especially economists, have favored the 2SLS approach regardless of whether treatment and outcome are continuous or binary. As such, many questions remain about the best approaches to IV estimation with such data. On one hand, linear probability models may not provide a good fit to the data, especially when treatment or outcome variables are "rare" or otherwise imbalanced in nature, which in turn may lead to imprecise estimates. On the other hand, probit and logit models may provide a better fit to observed data overall but generate biased estimates depending on the support of the residual distribution (across all X's). 1 The LATE effect is nonparametrically identified in a 2SLS setting within any cell defined by levels of all observed covariates X (Imbens & Angrist, 1994) . However, in a regression setting with many X's, where a full saturated model is typically not used, the consistency of estimating LATE would rely on the appropriateness of the linear model specification.
For example, Chapman and Brooks showed that small changes to the simulation settings of Terza et al. (2007) resulted in different results and conclusions about the properties of 2SLS and 2SRI. They showed that 2SLS produced consistent estimates of LATE across alternative scenarios whereas 2SRI estimates were not generally consistent for either ATE or LATE. However, the evidence produced by Chapman and Brooks is limited in that their scenarios all included two continuous IV and had treatment and outcome rates near 50%, a setting that may have inadvertently favored the 2SLS method.
Moreover, there is a debate in the health econometrics literature about the right form of the residual to be used in 2SRI approaches. Garrido, Deb, Burgess, and Penrod (2012) compared results from 2SRI models with different versions of residuals when applied to health expenditure data. They found that results varied widely depending on the type of residuals they use in the second stage. They raised the concern that raw residuals may not be the right control function variable. However, there is no theoretical rationale as to why different forms of the residual matter and the authors did not perform simulations to show which one is better. Chapman and Brooks' (2016) only considered 2SRI with raw residuals when showing the general inconsistency of 2SRI for ATE and LATE. Further, Chapman and Brooks (2016) did not report coverage probabilities for their estimates, a necessary component for making comparisons on properties of 2SLS and nonlinear 2SRI methods and for considering potential strengths and limitations of these approaches in practice.
In this paper, we try to provide theoretical and empirical evidence to inform these debates. 2 We first extend the recent assessment conducted by Chapman and Brooks (2016) using a simple scenario with a binary outcome, a binary treatment that is made endogenous by a continuous unobserved confounder, binary instrument, and a binary measured confounder. There is an abundance of examples in the applied health literature where such a full binary setting is of relevance. Our empirical example illustrates this case. 2SRI and 2SLS methods can also be applied to other settings such as for count data and expenditure models. This paper does not say anything about the performance of these estimators in those settings. After a theoretical discussion on the properties and expected behaviors of alternative estimators, we test the capability of 2SLS and alternative specifications of 2SRI methods for estimating alternative average treatment effect concepts across a range of simulation scenarios varying by the rarity of the treatment and the outcomes using extensive Monte Carlo simulation exercises.
Results show that the 2SLS method with binary IV produced consistent estimates of LATE across the entire range of rarity for either treatment or the outcome. The rarity of either did not affect the coverage probabilities of these estimators. In contrast, the 2SRI approach with any residuals studied was a biased estimator for LATE. In principle, nonlinear 2SRI estimators are designed to estimate the ATE parameter. However, 2SRI estimates of ATE were also generally biased, with the level of bias varying by residual form and outcome rarity. General conclusions from results of these simulation models are consistent with those of the more limited scenarios considered by Chapman and Brooks (2016) . Among 2SRI models, those using generalized residuals were most often least biased in estimating ATE, though 2SRI with Anscombe residuals generated less biased estimates in scenarios with very rare outcomes (<5%). Implications of these results are discussed.
Finally, we examined the implications of model choice using an empirical setting that resembles the simulated scenario with endogenous binary treatment, binary outcomes, and binary observable confounders. The alternative instrumental variable methods were applied to evaluate the effect of long-term care insurance on a variety of health care utilization outcomes using tax treatment as an instrument for long-term care insurance holding, as has been validated in the literature (Coe, Goda, & Van Houtven, 2015; Goda, 2011; Konetzka, He, Guo, & Nyman, 2014) . The results from applying the alternative estimators are discussed in the context of our simulation results.
| ECONOMETRIC THEORY AND METHODS
In what follows, we provide an intuitive explanation of the underlying theory of these methods rather than the full formal theory. 2 There are other forms of estimators that deal with a binary outcome and a binary endogenous treatment model, such as a GMM approaches (McCarthy & Tchernis, 2011) and semi-parametric estimators (Abadie, 2009; Abrevaya, Hausman, & Khan, 2010 , Chiburis, 2010 Shaikh & Vytlacil, 2011) . However, these estimators are not as popular as the 2SLS and the 2SRI approaches and so we do not cover them in this paper.
Consider the binary structural response model:
where the latent variable y i * follows a linear model of the form
where x i is a row vector of covariates and u i is a stochastic disturbance term for individual i. Throughout this section, bold face is used to represent a vector. If u i is independent of x i , a single index regression model such as
can be used to obtain consistent estimates of β. However, it may often be the case that u i is not independent of x i because some component of x i , say d i , is determined jointly with y i * such that
where ⊥ indicates statistical independence. Let the reduced form of d i , which we denote to be the endogenous binary treatment variable, be given as
where z i = vector of IV, λ is the true function through which d i is determined by w i and z i , v i is a stochastic disturbance term, and E (v i | w i , z i ) = 0 by construction. It is assumed throughout that expectation of d is a nontrivial function of z given w. For evaluation research, interest generally lies in estimating β parameters or, more specifically, the components of β that represent the causal effect of an exogenous shift in treatment, d i , on the response probabilities. The interpretation of those parameters of interest then must be considered. The broadest and perhaps most intuitive treatment effect parameter is the average treatment effect (ATE), which represents the mean change in an outcome that would be realized if everyone in a target population changed from not receiving treatment to receiving treatment. The ATE can be written as
where ATE (w) represents the conditional average treatment effect for a sample, which may be distinct in the mix of characteristics w.
If it is the case that treatment effects are heterogenous across the population and this heterogeneity is related to treatment choice (i.e., essential heterogeneity), then treatment effectiveness will vary over levels of u i when components of w are unmeasured by the researcher (i.e., there are unmeasured confounders). As a result, identification of ATE will require strong assumptions. First, the ATE can be estimated through identification of the function represented by G(.), which is to akin to identifying the full parametric distribution of u i . In the absence of full parametric assumptions, the ATE can be identified in special cases using IV methods, where the specified IV(s) fully identify the conditional distribution of u i | v i , which can then be integrated over the distribution of v i identified in the IV-based first-stage model. More simply put, the specified IV(s) must be considered as potentially influencing treatment choice for all types of individuals in the sample, defined by their levels of observed and unobserved characteristics. These IV assumptions may be particularly difficult to satisfy when a single binary instrument is used, as only two points of support in the distribution of v i are identified nonparametrically.
More generally, as Imbens and Angrist (1994) have shown, the IV effect estimated using a single binary IV, z i , is referred to as the local average treatment effect (LATE) and is given as
The LATE reflects the average causal effect of d i on the probability of y i among those (marginal) individuals whose treatment statuses would likely change with a change in the level of the instrumental variable (Imbens & Angrist, 1994 , 1996 Heckman, 1997) . The LATE parameter is only "locally" interpretable in the context of the instrument specified. Even with very strong instruments that lead all patients in the sample to be marginal, LATE will not often converge to the ATE because, unlike randomization, the instrument may put more weight on some marginal patient than others. Therefore, because it is often difficult to identify the marginal patients directly (i.e., to know for whom the instrument affected choice), it may also be difficult to understand to whom the estimate applies (Heckman, 1997; Newhouse & McClellan, 1998) . In some cases where a binary IV is related to a specific policy, LATE may be interpretable as the effect of changing d i among those individuals who would be induced to change their treatment status by the policy (Heckman et al., 2006) . Naturally, if the true treatment effect is constant, then the true LATE and ATE are the same.
The following discussion focuses on three popular approaches for estimation of mean effects on response probabilities from an instrument-driven exogenous shift in the treatment d i : The fully parametric bivariate probit (BVP) model, the semi-parametric residual inclusion (2SRI) approach, and the linear 2SLS approach. Each of these methods employs different assumptions and attempt to identify different parameters. In fact, Chiburis, Das, and Lokshin (2012) have argued that many of the documented differences in the treatment effect estimates from 2SLS and bivariate probit models in the literature may be driven by the fact that they are estimating different parameters to begin with. We now look at these estimators in detail.
| Approach 1 (fully parametric): For example, bivariate probit
If the joint distribution of the structural error term u i and the reduced form error term v i were parametrically specified (e.g., Gaussian), and λ(w i , z i ) is parametrically specified, then under some normalization of the Var(u i ) (Blundell & Smith, 1986 , 1989 ),
where ρ is the vector of population regression coefficients of u i on v i . The parameters β, λ(.) and ρ can be estimated using maximum likelihood estimation. When both y i and d i are binary, this approach can be implemented using a bivariate probit regression (Heckman, 1978) . However, bivariate probit models can be sensitive to heteroscedasticity and are usually more robust when treatment probabilities approach 0 or 1 (Chiburis et al., 2012) . If the underlying distributions are correctly specified, this method structurally recovers the ATE parameter because u i | v i , identified through the IV, is structurally linked to u i through the parametric assumption. The sample analog for the population treatment effect parameter identified by this approach is given by
where b · indicates that these quantities have been estimated from the data at hand.
| Approach 2 (semi-parametric): For example, 2SRI
The semi-parametric approach uses estimates of the reduced form error term, v i , to control for endogeneity of d i in the outcomes structural model (Blundell & Powell, 2004) . The identification of β 1 and the distribution functions of the error term, u i , is through distributional exclusion restrictions, the first of which requires that the dependence of u i on each of d i , w i and z i are completely characterized by the reduced form error vector v i :
Under this assumption,
where F(.) is the conditional c.d.f. of −u i given v i . The marginal distribution function G(.) with respect to −u i could be identified using a control function approach such as (Blundell & Powell, 2004) :
where H v is the distribution function of v. Consequently, ATE can be identified using (6). Note that, unlike the fully parametric approach, one can be agnostic about the parametric distribution of u i and v i as long as the distributional exclusion criterion is met. However, Blundell and Powell's (2003) identification relies on a continuous v i . Moreover, the identification of ATE relies on the fact that the error term in the outcomes model is additively separable. These conditions allow for a counterfactual to be determined without the need for any additional functional form assumptions given that the β are consistently estimated. However, in nonlinear models, such as those in (2), these counterfactuals inherently depend on the functional form assumption of the control function. For example, in practice, this approach is implemented through "residual inclusion," which follows estimating the error term in the first-stage regression and then including these estimated residuals as a covariate in the second-stage outcomes regression. A recycled predictions approach can then be used to recover the marginal effect of d i on E(y i ).
However, when implementing this approach for a binary treatment variable, the residuals from the first stage would always be positive for treatment recipients and negative for nonrecipients. Hence, in a nonlinear outcomes model, the conditional treatment effect, conditional on any level of the estimated v i (say, b v i ), must be obtained via extrapolation (Wooldridge, 2015) . Symmetry in the distribution of b v i , to the extent that it can be attained, can facilitate this extrapolation. Most forms of residuals used in nonlinear settings attempt to mimic a normal distribution. Alternate forms of residuals, such as standardized, deviance, Anscombe, and generalized (Gourieroux, Monfort, & Trognon, 1987) , may also be used in the residual inclusion approach and have been explored (Garrido et al., 2012) . When estimated by a nonlinear approach, such as probit or logit, raw-scale residuals for a binary treatment variable will always lie between 0 and 1 in absolute values. Therefore, each type of residual transformation is likely to spread the support of the residual distribution on the real line. For example, if predicted Pr(d|z) = 0.4 and 0.7 for two observations with d = 1, then the raw-scale residuals will be 0.6 and 0.3, respectively, but the standardized residuals (
) will be 1.22 and 0.65, respectively.
Consequently, standardized residuals may provide a better fit to the outcomes data and increase the robustness of extrapolations. For example, when the treatment is rare, the raw-scale residuals on either the negative or the positive side are likely to be far away from zero. Transformation can help these residuals to spread out, so as to increase accuracy when 
It is worth reiterating that a central problem, beyond the issue of nonoverlap in support of b v i as discussed above, when the instrumental variable is also binary is that only two points on the support of b v i are identified for any level of w. Model fit and extrapolation is based only on those two points in the support for b v i :
| Approach 3 (nonparametric): For example, 2SLS
Distinct from BVP and 2SRI approaches discussed above, which are designed to identify the ATE, a 2SLS approach is designed to estimate the LATE parameter. A 2SLS approach attempts to estimate the LATE from the data nonparametrically by estimating the slope of outcomes and exposure, conditional on the instrument. In the case of a single binary instrument, this slope is based upon the two points of support identified by the two levels of the instrument. That is, it plugs in the sample analogs of the numerator and the denominator in the LATE parameter defined above. However, this process assumes that the mean outcomes and the exposure models are linear in terms of w i .
3
When one or both of these linear specifications are violated, 2SLS may be a biased estimator for the outcome probabilities (Horrace & Oaxaca, 2006) . Although this could, in turn, induce bias in the estimation of LATE, some have suggested that risk of such bias is minimal in many applied settings and concerns are exaggerated. (Angrist & Fernandez-Val, 2013) .
The 2SLS approach of linear IV models can be viewed as a special case of control function methods (Telser, 1964) , where both first and second stage regressions are linear. However, because 2SLS approaches rely only on mean-independence requirements, and not on the full conditional independence of the distribution as in (8), demands the "correct" specification of the first stage to provide consistent estimates of the second-stage parameters (Blundell & Powell, 2004) . However, this requirement seems to apply mostly for the estimation of ATE, as the LATE value is not necessarily equivalent or determined by the true structural parameters under essential heterogeneity. It is unclear how violation of this requirement affects estimation of LATE. We expect that for a binary treatment in the first stage, a linear approximation of the conditional mean is likely to be most appropriate when the mean treatment is close to 50%. Chapman and Brooks (2016) simulation results showed that 2SLS methods produced unbiased estimates of the IV effect (i.e., weighted average of LATEs defined by the continuous IVs that they use) in models with treatment rates near 50% but did not consider binary instruments.
These discussions establish the rationale for the simulations in this paper. It is conjectured that 2SRI approach applied to binary endogenous variables can produce biased results when extrapolations are not appropriate. Alternative versions of the residuals could improve the performance of 2SRI approaches through mutating the scale of the residual distribution used, which could influence the estimation of the underlying structural functions through the 2SRI approach as was observed in Garrido et al. (2012) . Second, when the endogenous binary variable becomes rare, the linear model specification in the first stage could break down, resulting in biased estimation of second-stage parameters in the 2SLS approach. These biases could then compound biases from misfit of the linear model to rare outcomes in the second stage.
| SIMULATIONS
We consider the simplest case where we have a binary outcome (y i ), a binary treatment (d i ), three binary controls (w i ) and a binary instrument (z i ). We chose three binary controls so that the residuals from the first stage regression have at least 30 unique values in their support. The central questions we try to answer with these simulations are can linear approximation (2SLS) provide consistent estimates of the LATE for a binary outcome/binary endogenous variable model? What form of residuals are most suited to a correctly specified nonlinear 2SRI (ProbitProbit) approach? How do the results change if outcomes (y i ) and/or treatment (d i ) become rare?
The data generating processes (DGPs) are described below (subscripts i are suppressed for clarity).
| Exposure (treatment) DGP
where (α 1 , α 2 , α 3 ) = (0.5, 1, 2), α U = 1, α Z = 1. Observed variables w 1 , w 2 , w 3 , and z are all binary variables with mean equal to 0.5, generated by dichotomizing standard normal variables around the value of 0. Together, (α U · w U -ω) represents the empirical error term for the treatment model and consists of the binary unobserved confounder, w U , which is also based on dichotomizing a Normal(0,1), and the continuous model disturbance term, ω~Normal ( 
| Outcomes DGP
Together, (β U · w U -ε) represents the empirical error term, u, from the theoretical outcomes model under Section 2. Across all simulation models, true values of coefficients (β 1 , β 2 , β 3 ) were set to (1, 1, 1), the coefficient for the unmeasured confounder, β U , was set to 2, and coefficient on treatment, β D , was set to 1. The model disturbance term ε~Normal(0,1) and Pr(y|d) = Φ((β 0 + β D · d + 1.5)/√5.75)). We vary β 0 across simulations to take on values of −2, 0.5, 1.5, and 2.5 which correspond to Pr(y) = 0.51, 0.82, 0.93 and 0.96, respectively.
| Target parameters
The primary target parameters were the ATE and the LATE. True values for the ATE and LATE concepts were calculated in each simulation as
where w = (w 1 , w 2 , w 3, w u ). The true value of the LATE parameter was simulated based on 100 samples of 1 million observations each.
| Simulations
Estimates were generated using Monte Carlo simulation methods, using 1,000 samples of 50,000 observations each to mitigate finite sample issues and also to align our simulation with our empirical example. For each of the 1,000 simulated samples, 500 bootstrap resamples were drawn and used to calculate standard error and coverage values. Percent bias was calculated as ( b Δ k − LATE)*100/LATE or ( b Δ k − ATE)*100/ATE averaged over all simulated samples, where b Δ k is the estimated treatment effect for sample k. The coefficient of variation is based on the standard deviation of the mean estimates across the 1,000 Monte Carlo samples divided by the average of the mean estimates from those samples.
Finally, coverage probabilities for LATE and ATE were determined by averaging I((
, respectively, across all 1,000 samples, where I() is an indicator function and c SE k is the sample-specific standard error obtained via bootstrap. Simulations were repeated using a sample size of 5,000 to magnify any finite sample issues, and those results are presented in Appendix A.
| Estimators
We compared the following estimators:
1. IV regression with LPM (2SLS), 2. Probit-probit 2SRI with a. raw residuals
and B() is a beta function.
e. Generalized residuals (Gourieroux et al., 1987) :
3. Bivariate probit regression model, which is the MLE for the DGPs.
| Results
Descriptive statistics for our DGPs are provided in Table 1 . As expected, the true mean ATE parameter values varied across scenarios varying the intercept in the outcome models, β 0 , but not across scenarios varying the intercept in the treatment models. LATE, however, varies with the intercepts in both the outcome and treatment choice models. As outcomes become rare, following an underlying probit model, both ATE and LATE decrease. Simulation results are presented in Tables 2 and 3. Table 2 reports percent bias, the coefficient of variation, and coverage probabilities on the LATE. We find that 2SLS always provides consistent estimates of LATE, irrespective of the treatment rarity or outcomes rarity. This indicates that 2SLS can consistently estimate the LATE effect even if the linear probability model misfits the data and produces out of range predictions. Results do not show any major drop in coverage probabilities for LATE across simulation design points. Estimates from nonlinear 2SRI and bivariate probit were biased for the LATE. Table 3 reports percent bias, the coefficient of variation and coverage probabilities on the ATE. As expected, given the DGPs, bivariate probit always produced the least biased estimates of the ATE. Also as expected, 2SLS produced biased estimates of ATE, especially as the ATE and LATE became increasingly distinct in value with rarer treatment and outcome. Results showed that all of the 2SRI estimators produced substantially larger biases (and poor coverage probabilities) than bivariate probit in estimating ATE. This highlights the difficulty of estimating the ATE through extrapolation using the first-stage residuals. Among the residual inclusion approaches, 2SRI with generalized residual appeared to have the least bias in estimating ATE in most cases. However, the corresponding coverage probabilities were low.
One interesting observation was that, for rare outcomes (such as those below 5%), 2SRI with Anscombe residuals produced the least bias in estimating ATE, with coverage probabilities close to 95% in each case. The coverage probabilities did not deteriorate when treatment also became rare. This may indicate that the Anscombe transformation of the firststage residuals are helping to better approximate the distribution of u i |v i where the outcomes are rare and, therefore, abetting the extrapolation for the counterfactuals. Results for patterns of bias with 2SLS and 2SRI held similar for the simulations with a sample size of 5000 (Tables A1  and A2 ).
| EMPIRICAL EXAMPLE
To illustrate the potential impact of the estimation method on empirical results, we use the case of long-term care insurance (LTCI) and its impact on long-term care (LTC) utilization. This issue has been studied by Konetzka et al. (2014) and Coe et al. (2015) . This application is fitting to illustrate the concepts examined in the simulation models, as it is characterized by (a) a relatively low E(Y)-few elderly hold long-term care insurance; (b) an empirically strong and widely accepted instrumental variable-state tax policies that reduce the cost of insurance influence LTCI holding; and (c) multiple outcomes, at varying means Pr(Y).
| Data
Three main data sources were used, following Coe et al. (2015) : (a) the Health and Retirement Study (HRS; including RAND versions; http://hrsonline.isr.umich.edu/); (b) the HRS restricted geographic identifiers (HRS/G), in order to match the individual to the state of residence; and (c) state-level tax subsidy data for the purchase and holding of state-approved LTCI policies (GS Goda, 2011). Data from 10 waves of the HRS (1996-2010), a publicly available, biannual survey of the near elderly in the United States were used. 4 Respondents were ages 50 and older when they initially entered the sample, and many respondents are observed long enough to have used some type of long-term care. To increase the relevance of the instrumental variable used for analysis-the state tax subsidy-the sample was limited to individuals who report filing taxes and individuals in the top half of the income distribution in our sample. The sample size consisted of 46,639 individual-wave observations. The Cross-Wave Geographic Information (State) file matches respondents to their state of residence, which is then matched to hand-collected data from individual state income tax return forms from 1996-2010 that describe tax subsidy programs for private long-term care insurance.
| Measures and descriptive statistics
Five binary outcome measures were created; the measures had varying means to illustrate the bias due to the estimation methods. Each outcome measure is created from HRS data one wave (approximately two years) ahead of the data used to create explanatory measures described below. Descriptive statistics for the data are shown in Table 3 .
| Informal helper
Defining informal care in the HRS requires an algorithm based on several variables. The process first identifies whether the person received care for specific Instrumental activities of daily living (IADLS) and activities of daily living (ADLS) and then uses information from relationship codes measured in the helper file to determine whether the care was from a child, a friend, or another relative to ensure that the care recipient was not paid. We create three variables based on who provided the informal care: 60% of the sample receives informal care from any person; 43% receive informal care from a child; 16.5% receive care from other relatives.
| Home health care
The formal home health care variables are "Since the previous interview, has any medically-trained person come to your home to help you, yourself?" In 2000, the HRS clarified that medically trained persons include professional nurses, visiting nurse's aides, physical or occupational therapists, chemotherapists, and respiratory oxygen therapists, which may represent an expansion of the definition of home health care; 6.8% received home health care.
| Nursing home care
The HRS asks: "Since (Previous Wave Interview Month-Year/In the last two years), have you been a patient overnight in a nursing home, convalescent home, or other long-term health care facility?" For individuals who died between waves, nursing home use was measured from data in the HRS exit interviews; 2.3% received nursing home care. LTCI (mean = 0.157): Starting in the 1996 wave, respondents were asked to respond yes or no to the following question: "Not including government programs, do you now have any long-term care insurance which specifically covers nursing home care for a year or more or any part of personal or medical care in your home?" LTCI status is defined as having LTCI in year t, based on the recorded response to this question; 15.7% of individual waves had long-term care insurance.
State Tax Subsidy (an instrument for LTCI): Following the literature, a binary variable indicating whether a state has a tax subsidy available in a particular year was created to be used as an instrument for LCTI. The state tax subsidy indicated any subsidy, regardless of the form of the subsidy (i.e., credit or a deduction), the fraction of premiums eligible, monetary caps on the value of the subsidy, income limits, or whether the state subsidy was available in addition to the federal subsidy (GS Goda, 2011; Konetzka et al., 2014; Coe et al., 2015) . The availability of a state tax subsidy varied considerably over time and across states; although only three states had tax incentives for LTCI in 1996, 24 states plus the District of Columbia had adopted a subsidy by 2008. Prior literature has provided evidence that the state tax subsidy is empirically important in whether someone holds an LTCI policy and meets essential criteria for use as an instrumental variable in this context. In the first stage regression, the estimated coefficient on the binary state tax subsidy variable suggested that individuals in states with subsidies are about three percentage points more likely to own LTCI (F-stat: 65.93, p < .001).
| Individual-level control variables
Control variables in the models included binary variables indicating respondent's marital status, sex, number of children, retirement status, education, income, race, ethnicity, health status (fair or poor self-reported health and the presence of any limitations in the activities of daily living), and age fixed effects.
| Fixed effects
All models include year and state fixed effects. The year fixed effects account for time trends in the data whereas the state fixed effects account for non-time-varying differences across states. The inclusion of state fixed effects suggests that the empirical models identify the effect of LTCI coverage on the outcome for individuals whose LTCI coverage was sensitive to within-state differences in the state tax policy.
Analyses included the use of all estimators represented in the simulations models described in the previous section. Each estimator was used to estimate the effect of long-term care insurance on each of the five outcomes described above, using the binary state tax subsidy variable as an instrumental variable. For each estimator, estimates from 500 clustered bootstrap samples were used to compute standard errors for the marginal effect in each case.
| Results
The simulation results indicated that 2SLS should produce consistent estimates of LATEs, regardless of treatment or outcome rarity. Conversely, results suggested 2SRI models were likely to produce bias in estimating average treatment effects on outcomes (ATE or LATE), with generalized residuals estimator (2SRI-Gres) producing the least bias. For very rare outcome, such as nursing home care and home health care in our empirical application, 2SRI with Anscombe residual (2SRI-ares) may produce estimates close to the unbiased estimates of ATE. Table 4 provides summary statistics for outcomes and other variables used in the empirical models. The marginal effects and their bootstrapped standard errors are shown in Table 5 .
The 2SLS-based consistent LATE estimates for LTCI were −0.302 (Informal care from any source), −0.329 (Informal care from child), 0.161 (Informal care from relatives), −0.252 (home health care), and 0.087 (Any nursing home care). The interpretation of LATE always refers to the marginal individuals. For example, in the model predicting informal care from any source, the LATE estimate suggests that LTCI decreases the use of informal care from any source by 30 percentage points among people who are moved to acquire LTCI due to the subsidy. Sometimes, LATE can provide treatment effects estimates that are difficult to interpret and may even be considered nonsensical, even when the IV is policydriven. For example, assuming that access to LTCI would increase receipt of formal care, which will act as a substitute for all forms of informal care, the effect of LTCI on informal care from any source would perhaps not be expected to be smaller than the effect on Informal care from child, yet that is what LATE suggests. Similarly, it is difficult to envision how the effect from having LTCI, for those who have insurance due to state subsidies, increases informal care from a relative, though this LATE estimate does not reach statistical significance. One may invoke complicated stories about complementarity between formal care and informal care from relatives and particularities about the generosity of LTCI for those who have it due to state subsidies, to explain these result. Then again, the real world is full such complexities and taking the time to disentangle such nuanced relationships may be considered worthwhile. Note that the LATEs for different outcomes belong to the same marginal group of patients who are influenced by this specific IV.
Treatment effect estimates produced from the 2SRI models are often quite different from the 2SLS-based LATE estimates. This was expected. The 2SRI-Gres estimates of ATE for LTCI are −0.268 (informal care from any source), −0.179 (informal care from child), −0.111 (informal care from relatives), −0.077 (home health care), and 0.023 (Any nursing home care). Taken at face value, these estimates did not have the contextual inconsistencies, as it relates to our a priori theory about the relationships under study, which were seen in LATE estimates. The 2SRI estimates were also quite similar to those produced by the bi-probit model, especially when outcomes mean was close to 0.50. It is quite plausible that the underlying distribution of outcomes is well approximated by a normal distribution when the binary outcome mean is close to 0.50, and hence, for these outcomes, the bi-probit model is likely to produce consistent estimates of ATE.
5 For rarer outcomes, the bi-probit estimates and the 2SRI-gres estimates differ and it is not clear if any of those estimates are unbiased estimates of ATE. For any nursing home care, which is the rarest outcome, 2SRI-ares (with Anscombe residuals) estimates of ATE are close to being unbiased, according to our simulations. Although this point estimate of 0.038 differs from that of bi-probit (=0.023), neither reach statistical significance. Hence, it is reasonable to conclude that the overall average effect of LTCI in the entire population does not significantly affect any nursing home care. 5 Note that in contrast to our simulations, where we generate all outcomes under the normal distribution and found the BVP perform better for rare outcomes, here, we are suggesting that when the outcomes mean is around 50% its underlying data-generating process is more likely to be normal. 
| CONCLUSIONS
The economics literature is teeming with applications where linear probability models are used for binary outcomes. In case of IV methods, both the binary treatment (in the first stage) and the binary outcome (in the second stage) are often modeled with linear probability models with 2SLS estimators. In contrast, a control function approach may be used with nonlinear models (e.g., probit or logit applied to first-and/or second-stage models) where the estimated residuals from the first stage are used as an additional covariate in the second stage. However, the residual inclusion approach does not identify a treatment effect nonparametrically. Instead, it relies on extrapolation for the counterfactual outcomes conditional of the level of a residual using the functional form used. The proper characterization of these residuals is thought to be important to carry out such extrapolations. This research considered the case where a LATE parameter is nonparametrically identified using a binary instrument in the presence of all binary covariates. Extensive simulations that varied the rarity of both the outcome and treatment were performed to answer questions of whether 2SLS or 2SRI methods with different forms of residuals has the least bias in estimating the LATE or the ATE parameters.
Results show that the 2SLS method with binary IV, applied to a binary endogenous treatment and a binary outcome, produces consistent estimates of LATE across the entire range of rarity for either treatment or the outcome. The rarity of either does not affect the coverage probabilities of these estimators. In contrast, the 2SRI approach with any residuals studied was a biased estimator for LATE. However, in principle, the 2SRI estimators are designed to estimate the ATE parameter. Yet, still, results showed that 2SRI does not appear dependable for producing unbiased estimates of ATE. Rather, there were varying levels of bias associated with 2SRI estimates of ATE. Among the residual forms, 2SRI with generalized residuals appeared to produce the least biased estimates of the ATE. For very rare outcomes (<5%), 2SRI with Anscombe residual generated the least bias in estimating ATE. We conjecture that the symmetric transformation of these residuals may be leading to better extrapolation properties of the 2SRI estimators. However, whether these findings represent a general operating characteristic of 2SRI or are unique to our simulation settings is not known. However, our results are robust to alternative specification of outcomes model using logit or cloglog links (Tables A3 and A4) .
Results from this study conform with the simulation results of Chapman and Brooks (2016) , who compared 2SLS and nonlinear 2SRI with raw residuals in simulation models with binary treatment, binary outcome, and continuous instruments to find that 2SLS produced consistent estimates for the IV effect whereas 2SRI did not reliably estimate either the ATE or the IV effect. However, their study did not examine models with binary instruments, vary rarity of treatment or outcome from approximately 0.5, examine alternative forms of 2SRI residuals, or report coverage probabilities of estimates. The results of this study provide additional and more comprehensive evidence showing how 2SLS are consistent estimators of LATE over a wide range of scenarios varying by the rarity of binary outcomes and binary treatments.
We hope that this work will help the applied researcher to cautiously approach and interpret the results generated from IV estimation in models with binary treatment, binary outcome and binary instrumental variable. Careful interpretation of treatment effects that are identified and being estimated, as well as the potential for bias arising from methodologic decisions, are key factors to consider in conducting these analyses and responsibly reporting the results from them. Although estimating the LATE may be straightforward given a valid instrument, the interpretation of LATEs is often nuanced and may heighten the potential for unintentionally misleading or erroneous inferences and conclusions. On the other hand, interpreting population mean treatment effect parameters such as the ATE is straightforward but estimating them is often problematic and potentially infeasible, as doing so demands either richer data or a slew of statistical assumptions that may not be met. Moreover, under settings of essential heterogeneity in treatment effectiveness, the potential usefulness of a population-wide average effect may be limited and more nuanced parameters are required for practical impact. It is important that researchers understand precisely the assumptions underlying identification of alternative treatment effect concepts and the related theory to support an approach for estimating them. We are hopeful that our results and discussions can help untangle these challenges. 
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TABLE A4
Simulations results (N = 50,000) for average treatment effects (LATEs) with cloglog data generating process-%bias (Coeff. Var.) 
